Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The NIHR Oxford Biomedical Research Centre (BRC) has received more than €270,000 from the European Commission as a part of a multi-nation research project to promote citizen science.

Crowd of people

Oxford’s involvement will entail the BRC and the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) carrying out research into the role of steroid hormones in the treatment of non-alcoholic fatty liver disease (NAFLD), obesity and type 2 diabetes.

This would be a first study undertaken with a citizen science approach in the domain of Diabetes, Endocrinology and Metabolism in general and NAFLD in particular.

The Oxford researchers include OCDEM researcher and BRC Theme Lead for Diabetes and Metabolism, Prof Jeremy Tomlinson, as well as the BRC’s Chief Operating Officer, Dr Vasiliki Kiparoglou and BRC researcher Dr Syed Ghulam Sarwar Shah.

The full story is available on the Radcliffe Department of Medicine website

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.